Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.
Chlamydia pneumoniae
Legionella pneumophila
Mycoplasma pneumoniae
atypical pathogens
community-acquired bacterial pneumonia
lefamulin
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
04 Dec 2021
04 Dec 2021
Historique:
received:
01
10
2021
revised:
29
11
2021
accepted:
01
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
Lefamulin was the first systemic pleuromutilin antibiotic approved for intravenous and oral use in adults with community-acquired bacterial pneumonia based on two phase 3 trials (Lefamulin Evaluation Against Pneumonia [LEAP]-1 and LEAP-2). This pooled analysis evaluated lefamulin efficacy and safety in adults with community-acquired bacterial pneumonia caused by atypical pathogens (
Identifiants
pubmed: 34943700
pii: antibiotics10121489
doi: 10.3390/antibiotics10121489
pmc: PMC8698636
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Nabriva Therapeutics
ID : N/A
Références
J Emerg Med. 2021 Jun;60(6):781-792
pubmed: 33731270
Semin Respir Crit Care Med. 2016 Dec;37(6):819-828
pubmed: 27960206
J Antimicrob Chemother. 2019 Apr 1;74(Suppl 3):iii5-iii10
pubmed: 30949706
Intern Med. 2013;52(3):317-24
pubmed: 23370738
Medicine (Baltimore). 2015 Sep;94(36):e1474
pubmed: 26356705
J Antimicrob Chemother. 2017 May 1;72(5):1327-1333
pubmed: 28137939
Ann Fam Med. 2016 Nov;14(6):552-566
pubmed: 28376442
BMC Pulm Med. 2021 May 8;21(1):154
pubmed: 33964925
Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24
pubmed: 16669925
Chest. 2014 Feb;145(2):290-296
pubmed: 23764871
J Clin Microbiol. 2007 Aug;45(8):2726-30
pubmed: 17537933
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30670415
BMC Infect Dis. 2017 Jun 2;17(1):385
pubmed: 28576117
Clin Chest Med. 2017 Mar;38(1):45-58
pubmed: 28159161
Thorax. 2011 Apr;66(4):340-6
pubmed: 21257985
Intensive Care Med. 2016 Sep;42(9):1374-86
pubmed: 27276986
Ann Intensive Care. 2018 Aug 13;8(1):81
pubmed: 30105627
Diagn Microbiol Infect Dis. 2011 May;70(1):1-9
pubmed: 21397428
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858220
Lancet Infect Dis. 2014 Oct;14(10):1011-21
pubmed: 24970283
J Antimicrob Chemother. 2012 May;67(5):1170-5
pubmed: 22287234
EBioMedicine. 2015 Jul 17;2(9):1179-85
pubmed: 26501115
Clin Microbiol Infect. 2016 Aug;22(8):711-4
pubmed: 27297319
Pediatr Infect Dis J. 2009 Aug;28(8):693-6
pubmed: 19633515
Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72
pubmed: 17278083
J Antimicrob Chemother. 2014 Oct;69(10):2869-71
pubmed: 24898020
Expert Rev Respir Med. 2019 Feb;13(2):139-152
pubmed: 30596308
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27855075
Emerg Infect Dis. 2015 Aug;21(8):1470-2
pubmed: 26196107
JAMA. 2019 Nov 5;322(17):1661-1671
pubmed: 31560372
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Int J Infect Dis. 2015 Nov;40:102-7
pubmed: 25813554
J Mol Diagn. 2012 Sep;14(5):437-50
pubmed: 22819362
Chest. 2020 Sep;158(3):1008-1016
pubmed: 32298730
J Glob Antimicrob Resist. 2021 Nov 14;:
pubmed: 34788694
Clin Infect Dis. 2019 Nov 13;69(11):1856-1867
pubmed: 30722059
J Antimicrob Chemother. 2013 Mar;68(3):506-11
pubmed: 23169891
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31484701
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4407-11
pubmed: 27161634
BMC Infect Dis. 2012 Jun 12;12:134
pubmed: 22691449
Chin Med J (Engl). 2012 Sep;125(17):2967-72
pubmed: 22932165
J Antimicrob Chemother. 2019 Apr 1;74(Suppl 3):iii11-iii18
pubmed: 30949707
Euro Surveill. 2020 Jan;25(2):
pubmed: 31964459
Postgrad Med. 2010 Mar;122(2):130-41
pubmed: 20203464
Euro Surveill. 2015;20(48):30078
pubmed: 26675545
Respirology. 2016 Jan;21(1):65-75
pubmed: 26494527
Biomed Res Int. 2019 Mar 17;2019:7168949
pubmed: 31008110
J Pak Med Assoc. 2012 Jul;62(7):653-6
pubmed: 23866508
J Clin Microbiol. 2015 Jan;53(1):124-30
pubmed: 25355769
BMC Infect Dis. 2018 Dec 18;18(1):677
pubmed: 30563504